These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33738725)

  • 21. [Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea and antibiotic-associated diarrhea].
    Drozdov VN; Shikh EV; Astapovskii AA; Khalaidzheva KN; Solovieva SA; Dorogun OB
    Vopr Pitan; 2023; 92(4):92-103. PubMed ID: 37801459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
    Kane JS; Ford AC
    Expert Rev Gastroenterol Hepatol; 2016; 10(4):431-42. PubMed ID: 26753693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
    Carrasco-Labra A; Lytvyn L; Falck-Ytter Y; Surawicz CM; Chey WD
    Gastroenterology; 2019 Sep; 157(3):859-880. PubMed ID: 31351880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.
    Li G; Yang M; Jin Y; Li Y; Qian W; Xiong H; Song J; Hou X
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1220-1226. PubMed ID: 29194775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation?
    Piche T
    Neurogastroenterol Motil; 2014 Mar; 26(3):296-302. PubMed ID: 24548256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome.
    Hasler WL; Grabauskas G; Singh P; Owyang C
    Neurogastroenterol Motil; 2022 Jul; 34(7):e14339. PubMed ID: 35315179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of two laboratory model methods for diarrheal irritable bowel syndrome.
    Chen Q; Zhang H; Sun CY; He QY; Zhang RR; Luo BF; Zhou ZH; Chen XF
    Mol Med; 2023 Jan; 29(1):5. PubMed ID: 36635623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome.
    González-Castro AM; Martínez C; Salvo-Romero E; Fortea M; Pardo-Camacho C; Pérez-Berezo T; Alonso-Cotoner C; Santos J; Vicario M
    J Gastroenterol Hepatol; 2017 Jan; 32(1):53-63. PubMed ID: 27087165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine.
    Bafutto M; Almeida JR; Leite NV; Oliveira EC; Gabriel-Neto S; Rezende-Filho J
    Arq Gastroenterol; 2011; 48(1):36-40. PubMed ID: 21537540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zinc Deficiency and Intestinal Permeability in the Context of Rational Diagnostic and Drug Development for Diarrhea-Predominant Irritable Bowel Syndrome.
    Shah ED
    Dig Dis Sci; 2022 Aug; 67(8):3477-3478. PubMed ID: 35018534
    [No Abstract]   [Full Text] [Related]  

  • 32. Increased small intestinal permeability and RNA expression profiles of mucosa from terminal ileum in patients with diarrhoea-predominant irritable bowel syndrome.
    Li L; Xiong L; Yao J; Zhuang X; Zhang S; Yu Q; Xiao Y; Cui Y; Chen M
    Dig Liver Dis; 2016 Aug; 48(8):880-7. PubMed ID: 27246797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii.
    Bafutto M; Almeida JR; Leite NV; Costa MB; Oliveira EC; Resende-Filho J
    Arq Gastroenterol; 2013; 50(4):304-9. PubMed ID: 24474234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations.
    Martínez C; Vicario M; Ramos L; Lobo B; Mosquera JL; Alonso C; Sánchez A; Guilarte M; Antolín M; de Torres I; González-Castro AM; Pigrau M; Saperas E; Azpiroz F; Santos J
    Am J Gastroenterol; 2012 May; 107(5):736-46. PubMed ID: 22415197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome.
    Pigrau M; Rodiño-Janeiro BK; Casado-Bedmar M; Lobo B; Vicario M; Santos J; Alonso-Cotoner C
    Neurogastroenterol Motil; 2016 Apr; 28(4):463-86. PubMed ID: 26556786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial.
    Li Q; Zhang BP; Huang SG; Ouyang WW; Xie JH; Wen ZH; Yang XB
    Trials; 2018 Jul; 19(1):367. PubMed ID: 29996882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome.
    Camilleri M
    Expert Opin Pharmacother; 2013 Jun; 14(9):1151-60. PubMed ID: 23621801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
    Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
    Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baizhu shaoyao decoction restores the intestinal barrier and brain-gut axis balance to alleviate diarrhea-predominant irritable bowel syndrome via FoxO1/FoxO3a.
    Wei Y; Fan Y; Huang S; Lv J; Zhang Y; Hao Z
    Phytomedicine; 2024 Jan; 122():155163. PubMed ID: 37924689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of loperamide in gastrointestinal disorders.
    Hanauer SB
    Rev Gastroenterol Disord; 2008; 8(1):15-20. PubMed ID: 18477966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.